cysteine has been researched along with imatinib mesylate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lagonigro, MS; Miselli, F; Negri, T; Pilotti, S; Pricl, S; Tamborini, E | 1 |
| Angelo, LS; Kohanim, S; Kurzrock, R; Wu, JY; Yang, DJ | 1 |
| Barluenga, S; Leproult, E; Moras, D; Winssinger, N; Wurtz, JM | 1 |
| Dong, B; Huang, H; Qu, L; Weng, H; Zhao, P; Zhou, H | 1 |
| Adam, T; Faber, E; Friedecký, D; Karlíková, R; Mičová, K; Najdekr, L; Vrobel, I | 1 |
5 other study(ies) available for cysteine and imatinib mesylate
| Article | Year |
|---|---|
Re: Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis.
Topics: Alanine; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Cysteine; Fibroma; Humans; Imatinib Mesylate; Leucine; Methionine; Mutagenesis; Mutation; Piperazines; Polymorphism, Genetic; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Treatment Outcome | 2006 |
Molecular imaging of Bcr-Abl phosphokinase in a xenograft model.
Topics: Animals; Antibodies; Benzamides; Cysteine; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Indium Radioisotopes; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Nude; Phosphotyrosine; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Radioimmunodetection; Tumor Burden; Xenograft Model Antitumor Assays | 2009 |
Cysteine mapping in conformationally distinct kinase nucleotide binding sites: application to the design of selective covalent inhibitors.
Topics: Adenosine Triphosphate; Benzamides; Catalytic Domain; Cysteine; Drug Design; Humans; Imatinib Mesylate; Models, Molecular; Piperazines; Protein Conformation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Structure-Activity Relationship | 2011 |
Oridonin Triggers Chaperon-mediated Proteasomal Degradation of BCR-ABL in Leukemia.
Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Cell Line, Tumor; Cell Proliferation; Cysteine; Diterpenes, Kaurane; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Gene Deletion; Heat Shock Transcription Factors; HL-60 Cells; HSP70 Heat-Shock Proteins; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Models, Biological; Molecular Chaperones; Oxidation-Reduction; Proteasome Endopeptidase Complex; Proteolysis; Ubiquitin | 2017 |
Novel sulphur-containing imatinib metabolites found by untargeted LC-HRMS analysis.
Topics: Antineoplastic Agents; Chromatography, Liquid; Cysteine; Cystine; Humans; Imatinib Mesylate; Protein Kinase Inhibitors; Sulfur; Tandem Mass Spectrometry | 2017 |